VDR and secondary hyperparathyroidism: VDR polymorphisms are associated with adverse outcomes of transplantation such as the increased risk of graft rejection and viral infections [14,15], the severity of secondary hyperparathyroidism, bone density of kidney recipients [29], and an increased risk for bone diseases after transplantation [30].